All In MedTech

FDA Clearance Tracker · P180046-S061

Axonics Sacral Neuromodulation System (Urinary)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 1, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180046-S061
Device name
Axonics Sacral Neuromodulation System (Urinary)
Applicant location
Marlborough, MA
Received
Sep 19, 2022
Decided
Nov 1, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P180046

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Cirtec Medical Corporation, 99 Print Shop Road Enfield, CT 06082 as an alternate contract ethylene oxide sterilization facility for the Axonics Neurostimulator, Model 4101.

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.